who is interested in GT20029 GB today ?

Arthurandsam

Established Member
My Regimen
Reaction score
25
Gt20029 is BS, it's just another +7 hairs like cosmerna
 

bulli103

Member
Reaction score
12
i don`t belive cosmerna is +7 hairs.....i think it`s +-0....
gt20029 maybee is the same......still now, we don`t know about....
 

Modill

Established Member
My Regimen
Reaction score
121
I follow Spanish and English hairloss forums since 15 years ago, and I never saw a single product from any group buy that actually works. Change my mind.

Maybe someone has died due to any of this experimental drugs, we will never know. But regarding hair growth = 0
 

norton

Member
My Regimen
Reaction score
4
I’ve seen these before and even bought a few times.
Whoever is In charge, without the bs, these things always delay so long, when is the real ship time for this?
 

cuckthorn

Established Member
My Regimen
Reaction score
138
I just listened to this great podcast about a guy who just shaved his head, grew a beard and got jacked. They went on to say that it's just hair and confidence is everything. For example it doesn't matter if you look like a psychopathic sick monster, just walk up to women and be funny and confident and stuff. So we can all just do this.
 

duke213

Member
My Regimen
Reaction score
-5
Today, GT20029, a pioneering topical drug developed by Kintor Pharmaceuticals, has gained significant attention, particularly for its applications in treating androgenetic alopecia (Androgenetic Alopecia) and acne. Following the success of its Phase II clinical trials in China, which met the primary endpoint of improving hair density with minimal adverse effects, Kintor is now preparing for a Phase III trial in China and a Phase II trial in the U.S. for male Androgenetic Alopecia. The drug works carsflick by targeting androgen receptors in the skin to reduce local androgen sensitivity, offering a novel treatment with strong efficacy and safety results
 

Ralph Wiggum

Established Member
My Regimen
Reaction score
173
Today, GT20029, a pioneering topical drug developed by Kintor Pharmaceuticals, has gained significant attention, particularly for its applications in treating androgenetic alopecia (Androgenetic Alopecia) and acne. Following the success of its Phase II clinical trials in China, which met the primary endpoint of improving hair density with minimal adverse effects, Kintor is now preparing for a Phase III trial in China and a Phase II trial in the U.S. for male Androgenetic Alopecia. The drug works carsflick by targeting androgen receptors in the skin to reduce local androgen sensitivity, offering a novel treatment with strong efficacy and safety results
Thanks for chiming in, new bot friend!
mst3k_450.png
 

Ralph Wiggum

Established Member
My Regimen
Reaction score
173
Today, GT20029, a pioneering topical drug developed by Kintor Pharmaceuticals, has gained significant attention, particularly for its applications in treating androgenetic alopecia (Androgenetic Alopecia) and acne. Following the success of its Phase II clinical trials in China, which met the primary endpoint of improving hair density with minimal adverse effects, Kintor is now preparing for a Phase III trial in China and a Phase II trial in the U.S. for male Androgenetic Alopecia. The drug works carsflick by targeting androgen receptors in the skin to reduce local androgen sensitivity, offering a novel treatment with strong efficacy and safety results
Ha! I realized that this is the same bot that copied one of my posts verbatim in a thread a while ago.
 

callpizza

Member
My Regimen
Reaction score
12
Yes, unfortunately
But with this drug people no need to continue taking the sh*t finasteride... GT is only use 2 times a week
Kintor is out of money, the Phase III clinical trial has disappeared without a trace.
 

norton

Member
My Regimen
Reaction score
4
Yes, unfortunately
But with this drug people no need to continue taking the sh*t finasteride... GT is only use 2 times a week
I don’t know much about this GT but I would never drop fiasteride for it, the smart thing would be adding GT to the stack… so yes continue taking it
 
Top